ŞAHİN, B. Et Al. 2022. Meloxicam, a selective COX-2 inhibitor, displays anticonvulsive effects in pentylenetetrazole-induced acute seizures in mice through GABA and glutamate mediated mechanism. Experimental Biomedical Research , vol.5, no.1 , 48-57.

ŞAHİN, B., AKKAYA, R., & KARABULUT, S., (2022). Meloxicam, a selective COX-2 inhibitor, displays anticonvulsive effects in pentylenetetrazole-induced acute seizures in mice through GABA and glutamate mediated mechanism. Experimental Biomedical Research , vol.5, no.1, 48-57.

ŞAHİN, BİLAL, RECEP AKKAYA, And SEBAHATTİN KARABULUT. "Meloxicam, a selective COX-2 inhibitor, displays anticonvulsive effects in pentylenetetrazole-induced acute seizures in mice through GABA and glutamate mediated mechanism," Experimental Biomedical Research , vol.5, no.1, 48-57, 2022

ŞAHİN, BİLAL Et Al. "Meloxicam, a selective COX-2 inhibitor, displays anticonvulsive effects in pentylenetetrazole-induced acute seizures in mice through GABA and glutamate mediated mechanism." Experimental Biomedical Research , vol.5, no.1, pp.48-57, 2022

ŞAHİN, B. AKKAYA, R. And KARABULUT, S. (2022) . "Meloxicam, a selective COX-2 inhibitor, displays anticonvulsive effects in pentylenetetrazole-induced acute seizures in mice through GABA and glutamate mediated mechanism." Experimental Biomedical Research , vol.5, no.1, pp.48-57.

@article{article, author={BİLAL ŞAHİN Et Al. }, title={Meloxicam, a selective COX-2 inhibitor, displays anticonvulsive effects in pentylenetetrazole-induced acute seizures in mice through GABA and glutamate mediated mechanism}, journal={Experimental Biomedical Research}, year=2022, pages={48-57} }